Sort by
Refine Your Search
-
at risk of developing type 1 or type 2 diabetes. The Thurmond Lab is also examining Doc2b as a potential biomarker for diabetes. If this protein can help us detect early diabetic changes, patients can
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
information about Dr. Vu Ngo’s research, please visit here . As a successful candidate, you will: Plan, design, and execute experiments independently and in collaboration with lab members. Generate data
-
pertinent clinical and protocol information on request forms. Develop and maintain knowledge of various aspects of processing specimens, with particular attention to safety practices. Identify and communicate
-
hematopoiesis, leukemogenesis, and tumorigenesis as well as developing new targeted therapies for hematological malignant diseases and cancers. Our research involves experiments with various biochemistry and
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
drive our multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics
-
of adipose tissue and its link to age-related metabolic disorders and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique
-
failure from a developmental perspective. We are interested in the dynamics of beta-cell heterogeneity, islet organization and cell-cell interaction in fetal and neonatal development. The Dhawan lab